NOVEMBER 20255EUROPE20Martin Weilenmann,Managing DirectorAccertis36Magellan Biologics and Consulting28Tomasz Baran, MD,Chief Medical OfficerFamiCordTOP PHARMACEUTICAL MARKET CONSULTING SERVICE IN EUROPE 2025TOP TRANSIENT PROTEIN EXPRESSION MAMMALIAN CELL DEVELOPMENT IN EUROPE 2025TOP STEM CELL BANK IN EUROPE 2025CXO INSIGHTSThe Revolutionary Power of Cell and Gene TherapiesStefano Baila, Managing Director support Biologics (Cell and Gene), Eurofins16Global Patient Access Through Regulatory and MARKET ACCESS LeadershipPiero Rijli, Corporate Director, Regulatory Activities and Market Access, MENARINI Group21Navigating the Global Market Access Landscape with Purpose and Passion Ulf Staginnus, VP of International Market Access & Pricing, Blueprint Medicines24How to Best Navigate Innovation and Ethics in Life Sciences ComplianceRoswitha Reisinger, SVP General Counsel & Chief Compliance Officer, Kyowa Kirin International30Digital Health: A New Experience in the Healthcare SystemStefania Alvino, Head of Digital Innovation - Customer Experience Excellence Department & DSPACE, Daiichi Sankyo29Regulatory Intelligence as a Competitive Advantage in Generic Drug DevelopmentRafal Lunio, Director of Research & Development; Qualified Person (QP), Polfa Tarchomin S.A40Building Smarter, Safer and More Sustainable QA SystemsImane Rouggani, Group Director Global Quality Operations, Besins Healthcare32Leveraging in vitro diagnostics tests to transform cancer careMartin Bostrup, PhD, Executive Director, Market Access & Medical Affairs, EMEA, Veracyte38CXO INSIGHTSJérôme Puginier,General Manager,Magellan Biologics and Consulting
< Page 4 | Page 6 >